Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion type Assertion NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_head.
- NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion description "[These observations raise the possibility that application of PEDF may be helpful in designing new therapeutic strategies for neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, Alzheimer's disease and brain ischemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_provenance.
- NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion evidence source_evidence_literature NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_provenance.
- NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion SIO_000772 20236058 NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_provenance.
- NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion wasDerivedFrom befree-20150227 NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_provenance.
- NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_assertion wasGeneratedBy ECO_0000203 NP615591.RAlxasE7vywSSo07Uxb0ZCMwd3X4qTIKtKF6Yy-OJUIL8130_provenance.